Loading…

Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department

Aim FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department. Methods Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and Apri...

Full description

Saved in:
Bibliographic Details
Published in:Acute medicine & surgery 2024-01, Vol.11 (1), p.e934-n/a
Main Authors: Mihara, Yutaka, Komoriya, Kenta, Hagiwara, Kei, Hatanaka, Yasuhito, Shibahashi, Keita, Hikone, Mayu, Sugiyama, Kazuhiro
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53
container_end_page n/a
container_issue 1
container_start_page e934
container_title Acute medicine & surgery
container_volume 11
creator Mihara, Yutaka
Komoriya, Kenta
Hagiwara, Kei
Hatanaka, Yasuhito
Shibahashi, Keita
Hikone, Mayu
Sugiyama, Kazuhiro
description Aim FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department. Methods Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis. Results A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p 
doi_str_mv 10.1002/ams2.934
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c24ff07e394f4beebb06a70a4daed4e4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c24ff07e394f4beebb06a70a4daed4e4</doaj_id><sourcerecordid>3150086566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53</originalsourceid><addsrcrecordid>eNp1ks1u1DAQxyMEolWpxBMgS1y4pIw_4jgntFpRqFTEAThb_hgvXiXx4iRF-1I8BE-Gly2lReJky_PTT3_PTFU9p3BBAdhrM0zsouPiUXXKoGG1UrR9fO9-Up1P0xYAKAUuJX1anXAlGgDOTyu9cm7Jxu1JCiSbXfTE9il54pLZLL2ZYxrJjNMcxw3xeBMdksto1ybjzx8kjsSUap6jyXuCA-YNjsXlcWfyPOA4P6ueBNNPeH57nlVfLt9-Xr-vrz--u1qvrmvHOylqz2QwtPFdy1qukCOAFKFx0FKl0PAgaPCSMSWDKOF9Y43lTKFtJTqwDT-rro5en8xW73IcSiKdTNS_H1Le6JIouh61YyIEaJF3IgiLaC1I04IR3qAXKIrrzdG1W-yA3pVvZNM_kD6sjPGr3qQbTaGjUra8GF7dGnL6tpTu6SFODvvejJiWSbNOMKq6RkJBX_6DbtOSx9IrzWkZkpKNlH-FLqdpyhju0lDQhy3Qhy3QZQsK-uJ--jvwz8wLUB-B77HH_X9FevXhEzsIfwE88rys</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3150086566</pqid></control><display><type>article</type><title>Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Mihara, Yutaka ; Komoriya, Kenta ; Hagiwara, Kei ; Hatanaka, Yasuhito ; Shibahashi, Keita ; Hikone, Mayu ; Sugiyama, Kazuhiro</creator><creatorcontrib>Mihara, Yutaka ; Komoriya, Kenta ; Hagiwara, Kei ; Hatanaka, Yasuhito ; Shibahashi, Keita ; Hikone, Mayu ; Sugiyama, Kazuhiro</creatorcontrib><description>Aim FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department. Methods Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis. Results A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p &lt; 0.001, ρ = 0.76). FibCare® missed 14 out of 35 cases from patients with hypofibrinogenemia (fibrinogen ≤150 mg/dL assessed by the Clauss method). The discrepancy between the two measurements was significantly greater in specimens with lower fibrinogen levels and those obtained from patients following trauma. Conclusions FibCare®, a novel point‐of‐care testing device, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases. FibCare®, a novel point‐of‐care testing devise, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.</description><identifier>ISSN: 2052-8817</identifier><identifier>EISSN: 2052-8817</identifier><identifier>DOI: 10.1002/ams2.934</identifier><identifier>PMID: 38450033</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Accuracy ; blood coagulation ; diagnosis ; Emergency medical care ; emergency room ; fibrinogen ; Hemorrhage ; Molecular weight ; Original ; Patients ; Plasma ; Postpartum period ; trauma ; Viscoelasticity</subject><ispartof>Acute medicine &amp; surgery, 2024-01, Vol.11 (1), p.e934-n/a</ispartof><rights>2024 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.</rights><rights>2024 The Authors. Acute Medicine &amp; Surgery published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53</cites><orcidid>0009-0007-1004-9659 ; 0000-0001-5651-1449 ; 0000-0003-4104-386X ; 0009-0009-9980-1185</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3150086566/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3150086566?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,25731,27901,27902,36989,36990,44566,46027,46451,53766,53768,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38450033$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mihara, Yutaka</creatorcontrib><creatorcontrib>Komoriya, Kenta</creatorcontrib><creatorcontrib>Hagiwara, Kei</creatorcontrib><creatorcontrib>Hatanaka, Yasuhito</creatorcontrib><creatorcontrib>Shibahashi, Keita</creatorcontrib><creatorcontrib>Hikone, Mayu</creatorcontrib><creatorcontrib>Sugiyama, Kazuhiro</creatorcontrib><title>Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department</title><title>Acute medicine &amp; surgery</title><addtitle>Acute Med Surg</addtitle><description>Aim FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department. Methods Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis. Results A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p &lt; 0.001, ρ = 0.76). FibCare® missed 14 out of 35 cases from patients with hypofibrinogenemia (fibrinogen ≤150 mg/dL assessed by the Clauss method). The discrepancy between the two measurements was significantly greater in specimens with lower fibrinogen levels and those obtained from patients following trauma. Conclusions FibCare®, a novel point‐of‐care testing device, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases. FibCare®, a novel point‐of‐care testing devise, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.</description><subject>Accuracy</subject><subject>blood coagulation</subject><subject>diagnosis</subject><subject>Emergency medical care</subject><subject>emergency room</subject><subject>fibrinogen</subject><subject>Hemorrhage</subject><subject>Molecular weight</subject><subject>Original</subject><subject>Patients</subject><subject>Plasma</subject><subject>Postpartum period</subject><subject>trauma</subject><subject>Viscoelasticity</subject><issn>2052-8817</issn><issn>2052-8817</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ks1u1DAQxyMEolWpxBMgS1y4pIw_4jgntFpRqFTEAThb_hgvXiXx4iRF-1I8BE-Gly2lReJky_PTT3_PTFU9p3BBAdhrM0zsouPiUXXKoGG1UrR9fO9-Up1P0xYAKAUuJX1anXAlGgDOTyu9cm7Jxu1JCiSbXfTE9il54pLZLL2ZYxrJjNMcxw3xeBMdksto1ybjzx8kjsSUap6jyXuCA-YNjsXlcWfyPOA4P6ueBNNPeH57nlVfLt9-Xr-vrz--u1qvrmvHOylqz2QwtPFdy1qukCOAFKFx0FKl0PAgaPCSMSWDKOF9Y43lTKFtJTqwDT-rro5en8xW73IcSiKdTNS_H1Le6JIouh61YyIEaJF3IgiLaC1I04IR3qAXKIrrzdG1W-yA3pVvZNM_kD6sjPGr3qQbTaGjUra8GF7dGnL6tpTu6SFODvvejJiWSbNOMKq6RkJBX_6DbtOSx9IrzWkZkpKNlH-FLqdpyhju0lDQhy3Qhy3QZQsK-uJ--jvwz8wLUB-B77HH_X9FevXhEzsIfwE88rys</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Mihara, Yutaka</creator><creator>Komoriya, Kenta</creator><creator>Hagiwara, Kei</creator><creator>Hatanaka, Yasuhito</creator><creator>Shibahashi, Keita</creator><creator>Hikone, Mayu</creator><creator>Sugiyama, Kazuhiro</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0007-1004-9659</orcidid><orcidid>https://orcid.org/0000-0001-5651-1449</orcidid><orcidid>https://orcid.org/0000-0003-4104-386X</orcidid><orcidid>https://orcid.org/0009-0009-9980-1185</orcidid></search><sort><creationdate>202401</creationdate><title>Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department</title><author>Mihara, Yutaka ; Komoriya, Kenta ; Hagiwara, Kei ; Hatanaka, Yasuhito ; Shibahashi, Keita ; Hikone, Mayu ; Sugiyama, Kazuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Accuracy</topic><topic>blood coagulation</topic><topic>diagnosis</topic><topic>Emergency medical care</topic><topic>emergency room</topic><topic>fibrinogen</topic><topic>Hemorrhage</topic><topic>Molecular weight</topic><topic>Original</topic><topic>Patients</topic><topic>Plasma</topic><topic>Postpartum period</topic><topic>trauma</topic><topic>Viscoelasticity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mihara, Yutaka</creatorcontrib><creatorcontrib>Komoriya, Kenta</creatorcontrib><creatorcontrib>Hagiwara, Kei</creatorcontrib><creatorcontrib>Hatanaka, Yasuhito</creatorcontrib><creatorcontrib>Shibahashi, Keita</creatorcontrib><creatorcontrib>Hikone, Mayu</creatorcontrib><creatorcontrib>Sugiyama, Kazuhiro</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Acute medicine &amp; surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mihara, Yutaka</au><au>Komoriya, Kenta</au><au>Hagiwara, Kei</au><au>Hatanaka, Yasuhito</au><au>Shibahashi, Keita</au><au>Hikone, Mayu</au><au>Sugiyama, Kazuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department</atitle><jtitle>Acute medicine &amp; surgery</jtitle><addtitle>Acute Med Surg</addtitle><date>2024-01</date><risdate>2024</risdate><volume>11</volume><issue>1</issue><spage>e934</spage><epage>n/a</epage><pages>e934-n/a</pages><issn>2052-8817</issn><eissn>2052-8817</eissn><abstract>Aim FibCare® is a novel point‐of‐care testing device enabling prompt evaluation of fibrinogen levels. This study aimed to investigate the accuracy of FibCare® at a tertiary emergency department. Methods Blood specimens obtained at a tertiary emergency medical center between October 1, 2021, and April 30, 2023, were evaluated. The correlation between the fibrinogen levels assessed via FibCare® and those via the Clauss method was evaluated using the Spearman's test. The discrepancy between the two measurement methods was assessed according to fibrinogen level and diagnosis. Results A total of 177 specimens from 147 patients were eligible for the analysis. The median age of the patients was 49 years, and 109 (61.6%) were men. The two measurements had statistically significant but moderate correlation (p &lt; 0.001, ρ = 0.76). FibCare® missed 14 out of 35 cases from patients with hypofibrinogenemia (fibrinogen ≤150 mg/dL assessed by the Clauss method). The discrepancy between the two measurements was significantly greater in specimens with lower fibrinogen levels and those obtained from patients following trauma. Conclusions FibCare®, a novel point‐of‐care testing device, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases. FibCare®, a novel point‐of‐care testing devise, can be compatible with the Clauss method. However, clinicians should be aware of the risk that FibCare® may underestimate fibrinogen reduction, especially in severe cases and trauma cases.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38450033</pmid><doi>10.1002/ams2.934</doi><tpages>5</tpages><orcidid>https://orcid.org/0009-0007-1004-9659</orcidid><orcidid>https://orcid.org/0000-0001-5651-1449</orcidid><orcidid>https://orcid.org/0000-0003-4104-386X</orcidid><orcidid>https://orcid.org/0009-0009-9980-1185</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2052-8817
ispartof Acute medicine & surgery, 2024-01, Vol.11 (1), p.e934-n/a
issn 2052-8817
2052-8817
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c24ff07e394f4beebb06a70a4daed4e4
source Wiley-Blackwell Open Access Collection; Publicly Available Content (ProQuest); PubMed Central
subjects Accuracy
blood coagulation
diagnosis
Emergency medical care
emergency room
fibrinogen
Hemorrhage
Molecular weight
Original
Patients
Plasma
Postpartum period
trauma
Viscoelasticity
title Accuracy of rapid blood coagulation testing device FibCare® in a tertiary emergency department
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T17%3A57%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accuracy%20of%20rapid%20blood%20coagulation%20testing%20device%20FibCare%C2%AE%20in%20a%20tertiary%20emergency%20department&rft.jtitle=Acute%20medicine%20&%20surgery&rft.au=Mihara,%20Yutaka&rft.date=2024-01&rft.volume=11&rft.issue=1&rft.spage=e934&rft.epage=n/a&rft.pages=e934-n/a&rft.issn=2052-8817&rft.eissn=2052-8817&rft_id=info:doi/10.1002/ams2.934&rft_dat=%3Cproquest_doaj_%3E3150086566%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3964-d26fa15d972738e3e0064f5c07188ea3f41fd62286f4384d5bab328eb76ec0b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3150086566&rft_id=info:pmid/38450033&rfr_iscdi=true